Welcome to PsychU!

Using Remote Patient Monitoring to Provide Data-driven Health Care

Remote Patient Monitoring (RPM) involves the technology-based collection of data for the purpose of monitoring patients outside the hospital and transmitting the data to healthcare professional (HCPs).1,2​ RPM tools can highlight potentially significant changes in patient data, which HCPs can use to guide clinical decisions.3,4​ In this video, Dr. Timothy Aungst, PharmD will discuss RPM and how it can potentially help to improve patient care.  He will also discuss some of the challenges and future possibilities associated with RPM. 

Featuring:

Timothy-Aungst

Timothy Aungst, PharmD

Associate Professor of Pharmacy Practice Massachusetts College of Pharmacy and Health Sciences (MCPHS) Worcester, MA

More
Dr Aungst is an associate professor of pharmacy practice at MCPHS in Worcester, MA. He is also a clinical pharmacist at a home health care agency, with a focus on chronic disease medication management. Dr Aungst is a digital health advocate for the pharmacy space. His focus is on digital medicines and adherence development, the use of digital biomarkers in research, and the integration of digital therapeutics in patient care. He has served as an editor for iMedicalApps and as a writer for Pharmacy Times, with a focus on mobile apps and digital health. Dr Aungst has also spoken at national and international forums on these topics.
Mark-Tacelosky

Mark Tacelosky, PharmD (OPDC)

Senior Medical Science Liaison

References:

  1. Malasinghe LP et al. J Ambient Intell Human Comput. 2019;10:57–76. 
  2. Vegesna A et al. Telemed J E Health. 2017;23:3–17. 
  3. El-Rashidy N et al. Diagnostics. 2021;11:607.
  4. American Medical Association Digital Health Research. Physicians’ motivations and requirements for adopting digital health: Adoption and attitudinal shifts from 2016 to 2019. Published February 2020. Available at: https://www.ama-assn.org/system/files/2020-02/ama-digital-health-study.pdf. Accessed March 11, 2022.​

Speakers are paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI). Specific PsychU programs may be supported by OPDC, OAPI and other committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsor or the sponsors of the specific PsychU program in which such opinions are expressed. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC and OAPI.

US.CORP.X.22.00825 / US.CORP.D.22.00022 / US.CORP.X.22.00733